Public reporting on pharmaceutical industry-led access programs: alignment with the WHO medicine programs evaluation checklist
Background There has been increased demand for greater public accountability and transparency of private sector-led global health partnership programs. This study critically reviews and pilot tests the World Health Organization (WHO) medicine program checklist as a framework for public reporting and...
Saved in:
Main Authors: | Chukwuemeka A. Umeh (Author), Peter C. Rockers (Author), Richard Laing (Author), Ovi Wagh (Author), Veronika J. Wirtz (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Commercial and Social Value of Pharmaceutical Industry-led Access Programs: Conceptual Framework and Descriptive Analysis
by: Joshua Smith-Sreen, et al.
Published: (2022) -
Commitment to Impact: Strengthening Measurement of Industry-Led Access-to-Medicines Programs
by: Peter C. Rockers, et al.
Published: (2018) -
Coping with access barriers to non‐communicable disease medicines: qualitative patient interviews in eight counties in Kenya
by: Gloria Ng, et al.
Published: (2021) -
Estimating the Burden of Chagas Disease in the United States.
by: Jennifer Manne-Goehler, et al.
Published: (2016) -
Challenges of Guaranteeing Access to Medicines in Mexico: Lessons from Recent Changes in Pharmaceuticals Procurement
by: Octavio Gómez-Dantés, et al.
Published: (2022)